A Systematic Literature Review of Psychological Interventions for Adults with Type 1 Diabetes.

Diabetes type 1 Psychological intervention Randomised controlled trial Systematic review

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025

Informations de publication

Date de publication:
06 Jan 2024
Historique:
received: 25 09 2023
accepted: 14 11 2023
medline: 7 1 2024
pubmed: 7 1 2024
entrez: 6 1 2024
Statut: aheadofprint

Résumé

The psychological burden of type 1 diabetes mellitus (T1DM) is considerable. The condition affects the daily lives of adults living with T1DM (ALWT1DM) in many ways. International guidelines highlight the importance of providing psychological support to ALWT1DM to improve health outcomes and well-being. We conducted a systematic literature review of randomised controlled trials (RCTs) to identify the evidence on the impact of psychological interventions on glycaemic control and psychological outcomes in ALWT1DM. Literature searches of Medline, Embase, Cochrane Central Register of Controlled Trials, PsycInfo, and the grey literature were performed to identify relevant RCTs, published in English, from 2001 onward. Fourteen RCTs of ten psychological interventions in ALWT1DM were eligible and included in the qualitative synthesis. The studies varied considerably in terms of duration, target population, endpoints, and efficacy. Overall, psychological interventions did not perform significantly better than control treatments in improving glycaemic control, although selected patient groups did report benefits from some psychological intervention types, such as cognitive behavioural therapy. Although most of the psychological interventions produced small, nonsignificant improvements in self-reported patient functioning, some treatments were effective in reducing diabetes distress and improving mental health, even if no impact on glycaemic control was observed. Current guidelines for the treatment of T1DM recommend access to psychological services; however, there is a paucity of high-quality evidence from clinical trials on the effectiveness or preferred structure of psychological support. There is a clear need for more rigorous, large-scale, international research to address the efficacy of psychological interventions in ALWT1DM.

Identifiants

pubmed: 38183612
doi: 10.1007/s13300-023-01513-2
pii: 10.1007/s13300-023-01513-2
doi:

Types de publication

Journal Article Review

Langues

eng

Informations de copyright

© 2024. The Author(s).

Références

Green A, Hede SM, Patterson CC, et al. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64(12):2741–50. https://doi.org/10.1007/s00125-021-05571-8 .
doi: 10.1007/s00125-021-05571-8 pubmed: 34599655 pmcid: 8563635
van Duinkerken E, Snoek FJ, de Wit M. The cognitive and psychological effects of living with type 1 diabetes: a narrative review. Diabet Med. 2020;37(4):555–63. https://doi.org/10.1111/dme.14216 .
doi: 10.1111/dme.14216 pubmed: 31850538
Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(12):2126–40. https://doi.org/10.2337/dc16-2053 .
doi: 10.2337/dc16-2053 pubmed: 27879358 pmcid: 5127231
Cho MK, Kim MY. What affects quality of life for people with type 1 diabetes? A cross-sectional observational study. Int J Environ Res Public Health. 2021. https://doi.org/10.3390/ijerph18147623 .
doi: 10.3390/ijerph18147623 pubmed: 35010368 pmcid: 8751028
Benkel I, Arnby M, Molander U. Living with a chronic disease: a quantitative study of the views of patients with a chronic disease on the change in their life situation. SAGE Open Med. 2020. https://doi.org/10.1177/2050312120910350 .
doi: 10.1177/2050312120910350 pubmed: 32341782 pmcid: 7171994
Reddy M, Rilstone S, Cooper P, Oliver NS. Type 1 diabetes in adults: supporting self management. BMJ. 2016;352: i998. https://doi.org/10.1136/bmj.i998 .
doi: 10.1136/bmj.i998 pubmed: 26965473
Winkley K, Upsher R, Stahl D, et al. Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes. Diabet Med. 2020;37(5):735–46. https://doi.org/10.1111/dme.14264 .
doi: 10.1111/dme.14264 pubmed: 32022290 pmcid: 7217004
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71 .
doi: 10.1136/bmj.n71 pubmed: 33782057 pmcid: 8005924
Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). 2021. https://training.cochrane.org/handbook .
Cochrane Library. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2.0). 2019. https://methods.cochrane.org/risk-bias-20-tool .
Amsberg S, Anderbro T, Wredling R, et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients—a randomized controlled trial. Patient Educ Couns. 2009;77(1):72–80. https://doi.org/10.1016/j.pec.2009.01.015 .
doi: 10.1016/j.pec.2009.01.015 pubmed: 19297117
Didjurgeit U, Kruse J, Schmitz N, Stuckenschneider P, Sawicki PT. A time-limited, problem-orientated psychotherapeutic intervention in type 1 diabetic patients with complications: a randomized controlled trial. Diabet Med. 2002;19(10):814–21. https://doi.org/10.1046/j.1464-5491.2002.00811.x .
doi: 10.1046/j.1464-5491.2002.00811.x pubmed: 12358867
Fisher L, Hessler D, Polonsky WH, et al. T1-REDEEM: a randomized controlled trial to reduce diabetes distress among adults with type 1 diabetes. Diabetes Care. 2018;41(9):1862–9. https://doi.org/10.2337/dc18-0391 .
doi: 10.2337/dc18-0391 pubmed: 29976567 pmcid: 6105321
Mohn J, Graue M, Assmus J, et al. The effect of guided self-determination on self-management in persons with type 1 diabetes mellitus and HbA
doi: 10.1136/bmjopen-2016-013295 pubmed: 28674125 pmcid: 5734217
Morillas Jimenez V, Ruiz De Adana M, et al. Randomized trial to evaluate the addition of a mobile app (social diabetes) in adults with type 1 diabetes. Diabetes Technol Ther. 2020;22(Suppl 1):A-163. https://doi.org/10.1089/dia.2020.2525.abstracts .
doi: 10.1089/dia.2020.2525.abstracts
Rondags SM, de Wit M, Twisk JW, Snoek FJ. Effectiveness of Hypoaware, a brief partly web-based psychoeducational intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycemia: a cluster randomized controlled trial. Diabetes Care. 2016;39(12):2190–6. https://doi.org/10.2337/dc16-1614 .
doi: 10.2337/dc16-1614 pubmed: 27797931
Zoffmann V, Lauritzen T. Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial. Patient Educ Couns. 2006;64(1–3):78–86. https://doi.org/10.1016/j.pec.2005.11.017 .
doi: 10.1016/j.pec.2005.11.017 pubmed: 16720089
Zoffmann V, Vistisen D, Due-Christensen M. Flexible guided self-determination intervention for younger adults with poorly controlled type 1 diabetes, decreased HbA1c and psychosocial distress in women but not in men: a real-life RCT. Diabet Med. 2015;32(9):1239–46. https://doi.org/10.1111/dme.12698 .
doi: 10.1111/dme.12698 pubmed: 25601214
Ismail K, Thomas SM, Maissi E, et al. Motivational enhancement therapy with and without cognitive behavior therapy to treat type 1 diabetes: a randomized trial. Ann Intern Med. 2008;149(10):708–19.
doi: 10.7326/0003-4819-149-10-200811180-00005 pubmed: 19017589
Menting J, Tack CJ, van Bon AC, et al. Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5(6):448–56. https://doi.org/10.1016/S2213-8587(17)30098-0 .
doi: 10.1016/S2213-8587(17)30098-0 pubmed: 28462869
Petrak F, Herpertz S, Albus C, et al. Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the Diabetes and Depression (DAD) study: a randomized controlled multicenter trial. Diabetes Care. 2015;38(5):767–75. https://doi.org/10.2337/dc14-1599 .
doi: 10.2337/dc14-1599 pubmed: 25690005
van der Ven NC, Hogenelst MH, Tromp-Wever AM, et al. Short-term effects of cognitive behavioural group training (CBGT) in adult type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial. Diabet Med. 2005;22(11):1619–23. https://doi.org/10.1111/j.1464-5491.2005.01691.x .
doi: 10.1111/j.1464-5491.2005.01691.x pubmed: 16241932
Paschali AA, Peppou L, Benroubi M. Relaxation training significantly reduced blood glucose levels in patients with type 1 diabetes mellitus. Hormones. 2020;19(2):215–22. https://doi.org/10.1007/s42000-020-00187-w .
doi: 10.1007/s42000-020-00187-w pubmed: 32239448
Bisno DI, Reid MW, Fogel JL, Pyatak EA, Majidi S, Raymond JK. Virtual group appointments reduce distress and improve care management in young adults with type 1 diabetes. J Diabetes Sci Technol. 2021;16(6):1419–27. https://doi.org/10.1177/19322968211035768 .
doi: 10.1177/19322968211035768 pubmed: 34328029 pmcid: 9631532
Snoek FJ, Van Der Ven NCW, Twisk JWR, et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled type 1 diabetic patients: long-term effects on HbA
doi: 10.1111/j.1464-5491.2008.02595.x pubmed: 19046225
Efficace F, Cella D, Aaronson NK, et al. Impact of blinding on patient-reported outcome differences between treatment arms in cancer randomized controlled trials. J Natl Cancer Inst. 2022;114(3):471–4. https://doi.org/10.1093/jnci/djab177 .
doi: 10.1093/jnci/djab177 pubmed: 34508610
Yang X, Li Z, Sun J. Effects of cognitive behavioral therapy-based intervention on improving glycaemic, psychological, and physiological outcomes in adult patients with diabetes mellitus: a meta-analysis of randomized controlled trials. Front Psychiatry. 2020;11:711. https://doi.org/10.3389/fpsyt.2020.00711 .
doi: 10.3389/fpsyt.2020.00711 pubmed: 32848906 pmcid: 7399630
Vigersky RA, McMahon C. The relationship of hemoglobin A1c to time-in-range in patients with diabetes. Diabetes Technol Ther. 2019;21(2):81–5. https://doi.org/10.1089/dia.2018.0310 .
doi: 10.1089/dia.2018.0310 pubmed: 30575414
Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40(8):994–9. https://doi.org/10.2337/dc17-0636 .
doi: 10.2337/dc17-0636 pubmed: 28733374 pmcid: 5521971
Hu H, Sawhney M, Shi L, et al. A systematic review of the direct economic burden of type 2 diabetes in china. Diabetes Ther. 2015;6(1):7–16. https://doi.org/10.1007/s13300-015-0096-0 .
doi: 10.1007/s13300-015-0096-0 pubmed: 25652613 pmcid: 4374079
Wang W, Fu CW, Pan CY, et al. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health. 2009;12(6):923–9. https://doi.org/10.1111/j.1524-4733.2009.00561.x .
doi: 10.1111/j.1524-4733.2009.00561.x pubmed: 19824187
Menting J, Nikolaus S, Wiborg JF, et al. A web-based cognitive behaviour therapy for chronic fatigue in type 1 diabetes (Dia-Fit): study protocol for a randomised controlled trial. Trials. 2015;16:262. https://doi.org/10.1186/s13063-015-0764-4 .
doi: 10.1186/s13063-015-0764-4 pubmed: 26044447 pmcid: 4461902
Guidi J, Brakemeier E-L, Bockting CL, et al. Methodological recommendations for trials of psychological interventions. Psychother Psychosom. 2018;87(5):276–84.
doi: 10.1159/000490574 pubmed: 30007961
Alleaume C, Verger P, Peretti-Watel P. Psychological support in general population during the COVID-19 lockdown in France: needs and access. PLoS One. 2021;16(5):e0251707. https://doi.org/10.1371/journal.pone.0251707 .
doi: 10.1371/journal.pone.0251707 pubmed: 34014974 pmcid: 8136662

Auteurs

Onyinye Diribe (O)

Sanofi UK, 410 Thames Valley Park Drive, Reading, RG6 1PT, UK. onyi.diribe@sanofi.com.

Karen Palmer (K)

Sanofi UK, 410 Thames Valley Park Drive, Reading, RG6 1PT, UK.

Adee Kennedy (A)

Sanofi US, 55 Corporate Drive, Bridgewater, NJ, 08807, USA.

Marissa Betts (M)

Evidera, Inc., 5th Floor, 500 Totten Pond Road, Waltham, MA, 02451, USA.

Katarzyna Borkowska (K)

Evidera, Inc., Domaniewska 49, 02-672, Warsaw, Poland.

Cecile Dessapt-Baradez (C)

Sanofi UK, 410 Thames Valley Park Drive, Reading, RG6 1PT, UK.

Mike Baxter (M)

Department of Diabetes and Endocrinology, University of Swansea, Singleton Park, Swansea, SA2 8PP, UK.

Classifications MeSH